These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 18022003

  • 21. Differences in clinical profile and survival after heart transplantation according to prior heart disease.
    Agüero J, Almenar L, Martínez-Dolz L, Moro J, Izquierdo MT, Cano O, Salvador A.
    Transplant Proc; 2007 Sep; 39(7):2350-2. PubMed ID: 17889185
    [Abstract] [Full Text] [Related]

  • 22. Relationship of immunosuppression to Epstein-Barr viral load and lymphoproliferative disease in pediatric heart transplant patients.
    Schubert S, Renner C, Hammer M, Abdul-Khaliq H, Lehmkuhl HB, Berger F, Hetzer R, Reinke P.
    J Heart Lung Transplant; 2008 Jan; 27(1):100-5. PubMed ID: 18187094
    [Abstract] [Full Text] [Related]

  • 23. Pacemaker therapy for early and late sinus node dysfunction in orthotopic heart transplant recipients: a single-center experience.
    Luebbert JJ, Lee FA, Rosenfeld LE.
    Pacing Clin Electrophysiol; 2008 Sep; 31(9):1108-12. PubMed ID: 18834460
    [Abstract] [Full Text] [Related]

  • 24. Donor-specific HLA alloantibodies: long-term impact on cardiac allograft vasculopathy and mortality after heart transplant.
    Kaczmarek I, Deutsch MA, Kauke T, Beiras-Fernandez A, Schmoeckel M, Vicol C, Sodian R, Reichart B, Spannagl M, Ueberfuhr P.
    Exp Clin Transplant; 2008 Sep; 6(3):229-35. PubMed ID: 18954302
    [Abstract] [Full Text] [Related]

  • 25. A pooled analysis of posttransplant survival following combined heart-liver transplantation.
    Barshes NR, Udell IW, Joyce DL, Southard RE, O'Mahony CA, Goss JA.
    Transplantation; 2007 Jan 15; 83(1):95-8. PubMed ID: 17220801
    [Abstract] [Full Text] [Related]

  • 26. [Polyclonal activation due to Epstein-Barr virus superinfection in a case with chronic hepatitis B].
    Bakir Ozbey S, Mistik R, Gürcüoğlu E, Oral B, Göral G.
    Mikrobiyol Bul; 2007 Oct 15; 41(4):607-12. PubMed ID: 18173082
    [Abstract] [Full Text] [Related]

  • 27. Outcome of heart transplants 15 to 20 years ago: graft survival, post-transplant morbidity, and risk factors for mortality.
    Roussel JC, Baron O, Périgaud C, Bizouarn P, Pattier S, Habash O, Mugniot A, Petit T, Michaud JL, Heymann MF, Treilhaud M, Trochu JN, Gueffet JP, Lamirault G, Duveau D, Despins P.
    J Heart Lung Transplant; 2008 May 15; 27(5):486-93. PubMed ID: 18442713
    [Abstract] [Full Text] [Related]

  • 28. Diagnosis and treatment of post-transplantation lymphoproliferative disorder in pediatric heart transplant patients.
    Schubert S, Abdul-Khaliq H, Lehmkuhl HB, Yegitbasi M, Reinke P, Kebelmann-Betzig C, Hauptmann K, Gross-Wieltsch U, Hetzer R, Berger F.
    Pediatr Transplant; 2009 Feb 15; 13(1):54-62. PubMed ID: 18518912
    [Abstract] [Full Text] [Related]

  • 29. Prognostic impact of microvasculopathy on survival after heart transplantation: evidence from 9713 endomyocardial biopsies.
    Hiemann NE, Wellnhofer E, Knosalla C, Lehmkuhl HB, Stein J, Hetzer R, Meyer R.
    Circulation; 2007 Sep 11; 116(11):1274-82. PubMed ID: 17709643
    [Abstract] [Full Text] [Related]

  • 30. Anti-MICA antibodies are related to adverse outcome in heart transplant recipients.
    Kauke T, Kaczmarek I, Dick A, Schmoeckel M, Deutsch MA, Beiras-Fernandez A, Reichart B, Spannagl M.
    J Heart Lung Transplant; 2009 Apr 11; 28(4):305-11. PubMed ID: 19332255
    [Abstract] [Full Text] [Related]

  • 31. Follow-up study on the utility of von Willebrand factor levels in the diagnosis of cardiac allograft vasculopathy.
    Martínez-Dolz L, Almenar L, Reganon E, Vila V, Chamorro C, Andrés L, Martínez-Sales V, Moro J, Agüero J, Sánchez-Lázaro I, Salvador A.
    J Heart Lung Transplant; 2008 Jul 11; 27(7):760-6. PubMed ID: 18582806
    [Abstract] [Full Text] [Related]

  • 32. Vascular abnormalities and cardiomyocyte lipofuscin deposits in endomyocardial biopsy specimens of heart transplant recipients: are they related to the development of cardiac allograft vasculopathy?
    Zakliczynski M, Nozynski J, Konecka-Mrowka D, Krynicka-Mazurek A, Swierad M, Maruszewski M, Przybylski R, Zembala M.
    J Thorac Cardiovasc Surg; 2009 Jul 11; 138(1):215-21, 221.e1-3. PubMed ID: 19577082
    [Abstract] [Full Text] [Related]

  • 33. UNOS Liver Registry: ten year survivals.
    Waki K.
    Clin Transpl; 2006 Jul 11; ():29-39. PubMed ID: 18368704
    [Abstract] [Full Text] [Related]

  • 34. Influence of traditional cardiovascular risk factors in the recipient on the development of cardiac allograft vasculopathy after heart transplantation.
    Sánchez Lázaro IJ, Almenar Bonet L, Moro López J, Sánchez Lacuesta E, Martínez-Dolz L, Agüero Ramón-Llín J, Andrés Lalaguna L, Cano Pérez O, Ortiz Martínez V, Buendía Fuentes F, Salvador Sanz A.
    Transplant Proc; 2008 Nov 11; 40(9):3056-7. PubMed ID: 19010192
    [Abstract] [Full Text] [Related]

  • 35. Risk factors for the development of coronary artery disease of a grafted heart as detected very early after orthotopic heart transplantation.
    Kocík M, Málek I, Janek B, Zelízko M, Pirk J.
    Transpl Int; 2007 Aug 11; 20(8):666-74. PubMed ID: 17521382
    [Abstract] [Full Text] [Related]

  • 36. Incidence, treatment strategies and outcome of deep sternal wound infection after orthotopic heart transplantation.
    Filsoufi F, Rahmanian PB, Castillo JG, Pinney S, Broumand SR, Adams DH.
    J Heart Lung Transplant; 2007 Nov 11; 26(11):1084-90. PubMed ID: 18022072
    [Abstract] [Full Text] [Related]

  • 37. Orthotopic liver transplantation for hepatocellular carcinoma: a thirteen-year single-center experience.
    Castroagudín JF, Molina E, Bustamante M, Tomé S, Otero E, Martínez J, Segade FR, Conde R, Varo E.
    Transplant Proc; 2008 Nov 11; 40(9):2975-7. PubMed ID: 19010164
    [Abstract] [Full Text] [Related]

  • 38. Outcomes in bicaval versus biatrial techniques in heart transplantation: an analysis of the UNOS database.
    Weiss ES, Nwakanma LU, Russell SB, Conte JV, Shah AS.
    J Heart Lung Transplant; 2008 Feb 11; 27(2):178-83. PubMed ID: 18267224
    [Abstract] [Full Text] [Related]

  • 39. ABO-incompatible kidney transplantation using antigen-specific immunoadsorption and rituximab: a 3-year follow-up.
    Genberg H, Kumlien G, Wennberg L, Berg U, Tydén G.
    Transplantation; 2008 Jun 27; 85(12):1745-54. PubMed ID: 18580466
    [Abstract] [Full Text] [Related]

  • 40. Survival analysis in heart transplantation: results from an analysis of 1290 cases in a single center.
    Tjang YS, van der Heijden GJ, Tenderich G, Grobbee DE, Körfer R.
    Eur J Cardiothorac Surg; 2008 May 27; 33(5):856-61. PubMed ID: 18356067
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.